Loading...
XJPX
8283
Market cap1.85bUSD
Dec 05, Last price  
4,657.00JPY
1D
-0.87%
1Q
-0.19%
Jan 2017
68.61%
IPO
255.14%
Name

PALTAC Corp

Chart & Performance

D1W1MN
XJPX:8283 chart
P/E
12.59
P/S
0.24
EPS
369.83
Div Yield, %
2.13%
Shrs. gr., 5y
-0.37%
Rev. gr., 5y
2.57%
Revenues
1.19t
+3.14%
737,129,000,000739,170,000,000757,557,000,000765,654,000,000785,807,000,000831,884,000,000821,095,000,000860,329,000,000922,118,000,000966,689,000,0001,015,258,000,0001,046,415,000,0001,033,265,000,0001,045,734,000,0001,104,151,000,0001,151,965,000,0001,188,097,000,000
Net income
22.86b
+10.79%
8,671,000,0006,742,000,0003,430,000,0006,159,000,0008,397,000,0009,185,000,00010,268,000,00011,929,000,00014,605,000,00017,453,000,00019,767,000,00025,412,000,00019,317,000,00019,639,000,00019,251,000,00020,638,000,00022,864,000,000
CFO
20.68b
-22.83%
11,236,000,00011,713,000,0007,359,000,0006,742,000,00011,792,000,0003,340,000,00023,204,000,0005,226,000,00024,721,000,00024,107,000,00023,565,000,00021,005,000,00028,745,000,00021,949,000,00016,594,000,00026,790,000,00020,675,000,000
Dividend
Mar 30, 202663 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Paltac Corporation engages in the wholesale of cosmetics, daily necessities, and over-the-counter drugs in Japan. The company was founded in 1898 and is headquartered in Osaka, Japan. Paltac Corporation is a subsidiary of MediPal Holdings Corporation.
IPO date
Mar 18, 2010
Employees
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT